Advocacy means making the case for change - and in this case fighting malaria with all the means at our disposal to reduce the burden and suffering caused by the disease.

The number one advocacy priority of the Roll Back Malaria Partnership is to elicit transparency of both resources and results from all RBM Partners and other concerned with malaria - so that advocates can make persuasive use of that information to awaken policy makers and endemic communities to the imperative of rolling back malaria. The advocacy actions agreed by the RBM Advocacy Task Force are worded as numerical goals to obtain more resources and to demonstrate better results.

Global Advocacy Framework to Roll Back Malaria 2006-2015

Goal 1: Increase donor resources for scaling up malaria prevention, treatment and operational research to US$ 2.6 billion annually by 2010

• G8 Summit Declaration: Growth and Responsibility in Africa (8 June 2007)
• The DATA Report 2007: Keep the G8 Promise to Africa
• Global Fund Disbursements: by Region, Country and Grant Agreement
• Bulletin of the World Health Organization 2007: Estimated global resources needed to attain international malaria control goals
• APPMG 2007: Financing Mechanisms for Malaria (full report)

Goal 2: Increase the allocation of endemic country resources for scaling up malaria prevention, treatment and operational research to at least US$ 0.5 billion annually by 2010

• UNITAID
• Affordable Medicines Facility for Malaria (AMFm) Taskforce (previously Global ACT Subsidy)

Goal 3: Increase R&D resources for new drugs, vaccines, diagnostics, vector control measures and implementation research to US$ 1 billion annually

Goal 4: Ensure adherence to RBM's best practices for controlling malaria in all endemic countries, as presented in the RBM Global Strategic Plan 2005-2015

Goal 5: Mainstream malaria control into all health and development activities.